Symbol="IKNA"
AssetType="Common Stock"
Name="Ikena Oncology Inc"
Description="Ikena Oncology, Inc., a targeted oncology company, is focused on developing new cancer therapies that target key signaling pathways that drive cancer formation and spread. The company is headquartered in Boston, Massachusetts."
CIK="1835579"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="50 NORTHERN AVE., BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="207276000"
EBITDA="-66100000"
PERatio="None"
PEGRatio="None"
BookValue="3.705"
DividendPerShare="0"
DividendYield="0"
EPS="-1.75"
RevenuePerShareTTM="0.518"
ProfitMargin="0"
OperatingMarginTTM="-3.495"
ReturnOnAssetsTTM="-0.219"
ReturnOnEquityTTM="-0.379"
RevenueTTM="19168000"
GrossProfitTTM="-48703000"
DilutedEPSTTM="-1.75"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="4.246"
AnalystTargetPrice="17.33"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="3.126"
PriceToBookRatio="0.66"
EVToRevenue="0.208"
EVToEBITDA="0.968"
Beta="0.765"
num_52WeekHigh="7.64"
num_52WeekLow="1.94"
num_50DayMovingAverage="5.84"
num_200DayMovingAverage="4.48"
SharesOutstanding="42301300"
DividendDate="None"
ExDividendDate="None"
symbol="IKNA"
open="4.29"
high="5.03"
low="4.29"
price="4.90"
volume="96061.00"
latest_trading_day="2023-08-21"
previous_close="4.27"
change="0.63"
change_percent="14.7541%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="17"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="83"
Volume_recent_avg="108074"
Change_recent_avg="0.02"
Delta_recent_avg="0.53"
Variance_recent_avg="0.26"
Change_ratio_recent_avg="0.33"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="83"
Aroon_momentum_negative="17"
image_negative_thumbnail_id_1="504"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0101.jpeg"
image_negative_thumbnail_id_2="1129"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0162.jpeg"
image_neutral_thumbnail_id_1="527"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0072.jpeg"
image_neutral_thumbnail_id_2="523"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0076.jpeg"
image_positive_thumbnail_id_1="1000"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0162.jpeg"
image_positive_thumbnail_id_2="643"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0065.jpeg"
image_professor_thumbnail_id_1="1178"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
image_professor_thumbnail_id_2="1177"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
